An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder

American Journal of Dermatopathology

Volumn 33, Issue 3, 2011, Pages

  Patel, Jay L ^a   Shetty, Shashirekha ^a,b   Salama, Mohamed E ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

B cell lymphoma; blastic plasmacytoid dendritic cell neoplasm; cytogenetics; hematologic malignancy

Indexed keywords

CD123 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOPROLIFERATIVE DISORDER; B LYMPHOCYTE; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CELL AGGREGATION; CELL PROLIFERATION; CHROMOSOME ANALYSIS; CYTOGENETICS; DENDRITIC CELL SARCOMA; FLOW CYTOMETRY; FOREARM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPE; KARYOTYPE 45 XY; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIPLE CYCLE TREATMENT; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; RARE DISEASE; SKIN BIOPSY; SKIN TUMOR; SOFT TISSUE; SUBCUTANEOUS TISSUE; TUMOR CELL;

ANTIGENS, CD; B-LYMPHOCYTES; CHROMOSOME ABERRATIONS; DENDRITIC CELLS; DNA NUCLEOTIDYLEXOTRANSFERASE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79955521122     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181de9ce0     Document Type: Article

References (19)

1. DiGiuseppe JA, Louie DC, Williams JE, et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol. 1997; 21:1223-1230. (Pubitemid 27422323)
2. Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123:662-675. (Pubitemid 40586484)
3. Swerdlow SHCE, Harris NL, Jaffe ES, et al., ed. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008.
4. Jacob MC, Chaperot L, Mossuz P, et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica. 2003;88:941-955. (Pubitemid 37128095)
5. Petrella T, Comeau MR, Maynadie M, et al. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002;26:852-862. (Pubitemid 34752173)
6. Urosevic M, Conrad C, Kamarashev J, et al. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol. 2005;36:1020-1024. (Pubitemid 41253390)
7. Kato N, Yasukawa K, Kimura K, et al. CD2- CD4+ CD56+ hematodermic/ hematolymphoid malignancy. J Am Acad Dermatol. 2001;44:231-238.
8. Herling M, Jones D. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol. 2007;127:687-700.
9. Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 2002;99:1556-1563. (Pubitemid 34533026)
10. Garnache-Ottou F, Feuillard J, Saas P. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? Br J Haematol. 2007;136:539-548. (Pubitemid 46148191)
11. VermiW, Facchetti F, Rosati S, et al. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol. 2004;28: 585-595. (Pubitemid 38579559)
12. Kazakov DV, Mentzel T, Burg G, et al. Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? Br J Dermatol. 2003; 149:869-876. (Pubitemid 37412013)
13. Khoury JD, Medeiros LJ, Manning JT, et al. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer. 2002;94:2401-2408. (Pubitemid 34457121)
14. Pierre RV, Hoagland HC. Age-associated aneuploidy: loss of Y chromosome from human bone marrow cells with aging. Cancer. 1972;30: 889-894.
15. Wiktor A, Rybicki BA, Piao ZS, et al. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer. 2000;27: 11-16.
16. Wong AK, Fang B, Zhang L, et al. Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia/ myelodysplastic syndrome? Arch Pathol Lab Med. 2008;132:1329-1332.
17. Leroux D, Mugneret F, Callanan M, et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood. 2002;99:4154-4159. (Pubitemid 35332060)
18. Hallermann C, Middel P, Griesinger F, et al. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells. Eur J Dermatol. 2004;14: 317-322. (Pubitemid 39222332)
19. Hallermann C, Kaune KM, Tiemann M, et al. High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage. Ann Hematol. 2007;86:509-515.